According to the results of 2024, the pharmaceutical company PJSC Kyiv Vitamin Plant (KVZ) increased its net profit by 8.74% compared to 2023, to UAH 156.84 million.
According to the company’s disclosure to the National Securities and Stock Market Commission, its revenue from sales last year increased by 14.71% to UAH 4.944 billion.
As reported, at the end of 2022, Kyiv Vitamin Plant (KVZ) increased its net profit by 30.5% compared to 2022, to UAH 219.571 million.
KVZ is one of the ten largest pharmaceutical companies in Ukraine. The company’s product portfolio includes over 100 medicines and 20 dietary supplements.
According to the Opendatabot system, the ultimate beneficiary of KVZ is Canadian citizen Maxim Martin.
